Bryson R. Koehler - Feb 10, 2023 Form 4 Insider Report for EQUIFAX INC (EFX)

Role: EVP, CTO, Prod & D&A Officer
Signature: /s/Lisa Stockard as Attorney-in-Fact
Stock symbol: EFX
Transactions as of: Feb 10, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/14/2023, 03:14 PM
Previous filing: May 6, 2022
Next filing: Feb 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EFX	Common Stock	Award	$0	+4K	+17.47%	$0.00	26.9K	Feb 10, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EFX	Stock Option/Right to Buy	Award	$0	+12.8K		$0.00	12.8K	Feb 10, 2023	Common Stock	12.8K	$206.16	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026.
F2	Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3	Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2024.